FBLN2 and breast cancer: High FBLN2 expression is also known to be prognostic in liver (favourable) and in endometrial cancers (unfavourable) [28] (Human Protein Atlas available from http://www.proteinatlas.org, accessed on the 1st December 2020), and dysregulation of Fibulin-2 is involved in the development of breast cancer [24], Kaposi’s sarcoma and pancreatic cancer [22].